BofA/Merrill Lynch Starts Surgery Partners (SGRY) at Buy
Tweet
Share
E-mailGet Alerts SGRY Hot Sheet
Price: $15.31 +2.48%
Rating Summary:
12 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
12 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
BofA/Merrill Lynch initiated coverage on Surgery Partners (NASDAQ: SGRY) with a Buy rating and a price target of $27.00.
For an analyst ratings summary and ratings history on Surgery Partners click here. For more ratings news on Surgery Partners click here.
Shares of Surgery Partners closed at $17.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Resumes Williams-Sonoma (WSM) at Buy
- Freedom Broker Starts CarGurus Inc. (CARG) at Buy
- SpaceX prices IPO at $135 per share for June 12 Nasdaq debut
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
